Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future - Centre de recherche des Cordeliers Accéder directement au contenu
Article Dans Une Revue ESMO Open Année : 2021

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

P. Hofman (1) , M. Ilié (1, 2, 3) , E. Chamorey (4) , P. Brest (1, 4) , R. Schiappa (4) , V. Nakache (1) , M. Antoine (5) , M. Barberis (6) , H. Begueret (7) , F. Bibeau (8, 9) , C. Bonnetaud (1) , P. Boström (10) , P. Brousset (11, 12) , L. Bubendorf (13) , L. Carvalho (14) , G. Cathomas (15) , A. Cazes (16) , L. Chalabreysse (17, 18) , M.-P. Chenard (19) , M.-C. Copin (20, 21) , J.-F. Côté (22) , D. Damotte (23, 24) , L. de Leval (25) , P. Delongova (26) , V. Thomas de Montpreville (27) , A. de Muret (28) , A. Dema (29) , W. Dietmaier (30) , M. Evert (30) , A. Fabre (31) , F. Forest (32) , A. Foulet (33) , S. Garcia (34, 35) , M. Garcia-Martos (36) , L. Gibault (37) , G. Gorkiewicz (38) , D. Jonigk (39) , J. Gosney (40) , A. Hofman (1, 2, 3) , I. Kern (41) , K. Kerr (42) , M. Kossai (43) , M. Kriegsmann (44) , S. Lassalle (1, 2, 3) , E. Long-Mira (1, 2, 3) , A. Lupo (23, 24) , A. Mamilos (30) , R. Matěj (45) , J. Meilleroux (12, 11) , C. Ortiz-Villalón (46) , L. Panico (47) , A. Panizo (48) , M. Papotti (49) , P. Pauwels (50) , G. Pelosi (51) , F. Penault-Llorca (43) , O. Pop (52) , N. Poté (16, 53) , S.R.Y. Cajal (54) , J.-C. Sabourin (55, 56) , I. Salmon (57) , M. Sajin (58) , S. Savic-Prince (13) , H.-U. Schildhaus (59) , P. Schirmacher (44) , I. Serre (60) , E. Shaw (61) , D. Sizaret (28) , A. Stenzinger (44) , J. Stojsic (62) , E. Thunnissen (63) , W. Timens (64) , G. Troncone (65) , C. Werlein (39) , H. Wolff (66) , J.-P. Berthet (2, 3) , J. Benzaquen (2, 3, 1) , C.-H. Marquette (2, 3, 1) , V. Hofman (2, 3, 1) , F. Calabrese (67)
1 IRCAN - Institut de Recherche sur le Cancer et le Vieillissement
2 OncoAge - FHU OncoAge - Pathologies liées à l’âge [CHU Nice]
3 UniCA - Université Côte d'Azur
4 UNICANCER/CAL - Centre de Lutte contre le Cancer Antoine Lacassagne [Nice]
5 CHU Tenon [AP-HP]
6 EIO - European Institute of Oncology IRCCS [Milan, Italy]
7 CHU Bordeaux
8 CHU Caen
9 UNICAEN - Université de Caen Normandie
10 TYKS - Turku University Hospital
11 CRCT - Centre de Recherches en Cancérologie de Toulouse
12 IUCT Oncopole - UMR 1037 - Institut Universitaire du Cancer de Toulouse - Oncopole
13 University Hospital Basel [Basel]
14 UC - University of Coimbra [Portugal]
15 KSBL - Kantonsspital Baselland [Bruderholz]
16 PHERE (UMR_S_1152 / U1152) - Physiopathologie et Epidémiologie des Maladies Respiratoires
17 Groupement Hospitalier Est [Bron]
18 HCL - Hospices Civils de Lyon
19 CHU Strasbourg - Centre Hospitalier Universitaire [Strasbourg]
20 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
21 Université de Lille
22 IMM - Institut Mutualiste de Montsouris
23 CRC (UMR_S_1138 / U1138) - Centre de Recherche des Cordeliers
24 Hôpital Cochin [AP-HP]
25 UNIL - Université de Lausanne = University of Lausanne
26 University Hospital Ostrava
27 CCML - Centre Chirurgical Marie Lannelongue
28 CHU Trousseau [Tours]
29 UMFT - Victor Babeş University of Medicine and Pharmacy
30 University of Regensburg
31 UCD - University College Dublin [Dublin]
32 CHU ST-E - Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne]
33 Centre Hospitalier Le Mans (CH Le Mans)
34 AP‐MM Marseille - Hôpital Nord AP‐MM Marseille, France
35 AMU - Aix Marseille Université
36 Hospital General Universitario "Gregorio Marañón" [Madrid]
37 HEGP - Hôpital Européen Georges Pompidou [APHP]
38 Karl-Franzens-Universität Graz
39 MHH - Medizinische Hochschule Hannover = Hannover Medical School
40 Royal Liverpool University Hospital
41 University Clinic Golnik
42 Aberdeen Royal Infirmary, Aberdeen
43 UNICANCER/CJP - Centre Jean Perrin [Clermont-Ferrand]
44 Heidelberg University Hospital [Heidelberg]
45 UK - Univerzita Karlova [Praha, Česká republika] = Charles University [Prague, Czech Republic]
46 Karolinska University Hospital [Stockholm]
47 Monaldi-Cotugno-CTO
48 Complejo Hospitalario de Navarra
49 UNITO - Università degli studi di Torino = University of Turin
50 UA - University of Antwerp
51 UNIMI - Università degli Studi di Milano = University of Milan
52 University of Oradea
53 AP-HP - Hôpital Bichat - Claude Bernard [Paris]
54 Vall d'Hebron University Hospital [Barcelona]
55 GPMCND - Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques
56 CHU Rouen
57 ULB - Université libre de Bruxelles
58 UMPCD - University of Medicine and Pharmacy “Carol Davila” Bucharest
59 AöR - University Hospital Essen
60 Hôpital Gui de Chauliac [CHU Montpellier]
61 University Hospital Southampton NHS Foundation Trust
62 University of Belgrade [Serbia]
63 UvA - University of Amsterdam [Amsterdam] = Universiteit van Amsterdam
64 University of Groningen [Groningen]
65 University of Naples Federico II = Università degli studi di Napoli Federico II
66 FIOH - Finnish Institute of Occupational Health of Helsinki
67 Unipd - Università degli Studi di Padova = University of Padua
M. Antoine
  • Fonction : Auteur
H. Begueret
  • Fonction : Auteur
I. Kern
  • Fonction : Auteur
L. Panico
  • Fonction : Auteur
P. Pauwels
  • Fonction : Auteur
F. Penault-Llorca
O. Pop
  • Fonction : Auteur
D. Sizaret
  • Fonction : Auteur

Résumé

Background This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. Materials and methods A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training during the COVID-19 crisis, from 15 March to 31 May 2020, compared with the same period in 2019. Results Questionnaires were returned from 53/71 (75%) laboratories from 18 European countries. The biosafety procedures were heterogeneous. The workload in clinical and molecular pathology decreased dramatically by 31% (range, 3%-55%) and 26% (range, 7%-62%), respectively. According to the professional category, between 28% and 41% of the staff members were not present in the laboratories but did teleworking. A total of 70% of the laboratories developed virtual meetings for the training of residents and junior pathologists. During the period of study, none of the staff members with confirmed COVID-19 became infected as a result of handling samples. Conclusions The COVID-19 pandemic has had a strong impact on most of the European pathology laboratories included in this study. Urgent implementation of several changes to the organization of most of these laboratories, notably to better harmonize biosafety procedures, was noted at the onset of the pandemic and maintained in the event of a new wave of infection occurring in Europe.
Fichier principal
Vignette du fichier
PIIS2059702920328891.pdf (603.92 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03346140 , version 1 (22-09-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

P. Hofman, M. Ilié, E. Chamorey, P. Brest, R. Schiappa, et al.. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future. ESMO Open, 2021, 6 (1), pp.100024. ⟨10.1016/j.esmoop.2020.100024⟩. ⟨hal-03346140⟩
110 Consultations
40 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More